Amgen Unusual Options Activity

Benzinga03:02

Watch Now: ETF Edge on Reshoring Trends, Weight Loss Drugs and More

CNBC00:15

Alnylam, Lilly, AstraZeneca Among Best Performing Pharmas, Biotechs in Q2

Seeking AlphaJul 1 08:30

Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report

Seeking AlphaJun 30 03:44

Amgen Is Maintained at Buy by Argus Research

Dow JonesJun 28 01:57

Argus Research Maintains Buy on Amgen, Raises Price Target to $340

BenzingaJun 28 01:47